HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)
China flag China · Delayed Price · Currency is CNY
11.29
+0.18 (1.62%)
Feb 3, 2026, 3:00 PM CST

SHA:600829 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
620.291,1001,3141,181800.49418.7
Cash & Short-Term Investments
620.291,1001,3141,181800.49418.7
Cash Growth
-22.06%-16.32%11.25%47.59%91.18%14.02%
Accounts Receivable
4,6674,3504,3854,1684,1823,860
Other Receivables
19.0153.1364.9647.2640.914.04
Receivables
4,6864,4034,4504,2154,2223,864
Inventory
1,1161,1011,1151,0741,1051,123
Prepaid Expenses
-9.981.794.598.44-
Other Current Assets
120.5272.8342.871.0148.78129.95
Total Current Assets
6,5436,6876,9256,5466,1855,536
Property, Plant & Equipment
327.26335.85346.13367.81410.84312.43
Other Intangible Assets
26.5628.0826.528.0129.2926.59
Long-Term Deferred Tax Assets
82.1567.4567.6964.2567.1565.24
Long-Term Deferred Charges
7.7410.4811.211.8112.089.93
Other Long-Term Assets
35.7137.4250.340.5443.1445.16
Total Assets
7,0227,1667,4267,0596,7485,995
Accounts Payable
2,7202,7812,9142,6142,4782,671
Accrued Expenses
18.2234.2444.7350.2430.7289.69
Short-Term Debt
685839.22962.081,1981,233610.7
Current Portion of Leases
26.4430.5627.6932.0935.18-
Current Income Taxes Payable
38.625.8443.3327.3834.9238.4
Current Unearned Revenue
17.9415.1215.9911.4513.312.33
Other Current Liabilities
380.92408.3512.7498.47531.72440.44
Total Current Liabilities
3,8874,1344,5214,4314,3573,863
Long-Term Leases
22.430.3729.4138.4859.59-
Long-Term Unearned Revenue
114.68117.09120.94125.71130.77137.34
Long-Term Deferred Tax Liabilities
4.563.74.054.51--
Other Long-Term Liabilities
--0.140.571.562.58
Total Liabilities
4,0294,2854,6754,6014,5494,003
Common Stock
579.89579.89579.89579.89579.89579.89
Retained Earnings
2,4132,3012,1721,8791,6201,413
Total Common Equity
2,9932,8812,7512,4592,2001,993
Minority Interest
-0.04-0.04-0.04-1.06-1.02-0.24
Shareholders' Equity
2,9932,8812,7512,4582,1991,992
Total Liabilities & Equity
7,0227,1667,4267,0596,7485,995
Total Debt
733.84900.151,0191,2681,328610.7
Net Cash (Debt)
-113.55199.69295.17-86.9-527.08-191.99
Net Cash Growth
--32.35%----
Net Cash Per Share
-0.200.340.51-0.15-0.91-0.33
Filing Date Shares Outstanding
579.89579.89579.89579.89579.89579.89
Total Common Shares Outstanding
579.89579.89579.89579.89579.89579.89
Working Capital
2,6552,5532,4042,1151,8291,673
Book Value Per Share
5.164.974.744.243.793.44
Tangible Book Value
2,9672,8532,7252,4312,1711,966
Tangible Book Value Per Share
5.124.924.704.193.743.39
Buildings
-372.04372.04374.91374.93376.61
Machinery
-145.84147.21146.43149.73152.94
Construction In Progress
-57.4759.6260.4260.4260.42
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.